1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Heart Failure With Reduced Ejection Fraction: new trials by email Literature Review of Heart Failure With Reduced Ejection Fraction trials Research Report on Heart Failure With Reduced Ejection Fraction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effectiveness of CRD-740 in Heart Failure CRD-740, Placebo - Heart Failure, Heart Failure With Reduced Ejection Fraction | Phase 2 | Terminated | Cardurion Pharmaceuticals, Inc. | 60 | 2022-05-26 | 2024-12-19 |
Cardiovascular Diseases (1) · Heart Diseases (1) · Heart Failure (1)
Cardurion Pharmaceuticals, Inc. (1)
Canada (1) · Israel (1) · United Kingdom (1) · United States (1)
Howard Surks, MD (1)